Vertex Pharmaceuticals Incorporated【VRTX】 利益剰余金の推移
機能の使い方
|
（単位：百万ドル）
|
利益剰余金
|
前年比（％）
|
|
4Q25
|
13,560
|
+41.2%
|
|
3Q25
|
12,369
|
+42.3%
|
|
2Q25
|
11,286
|
+47.6%
|
|
1Q25
|
10,253
|
-8.8%
|
|
4Q24
|
9,607
|
-5.3%
|
|
3Q24
|
8,694
|
-5.2%
|
|
2Q24
|
7,648
|
-6.0%
|
|
1Q24
|
11,242
|
+55.7%
|
|
4Q23
|
10,142
|
+55.5%
|
|
3Q23
|
9,174
|
+60.8%
|
|
2Q23
|
8,138
|
+70.5%
|
|
1Q23
|
7,223
|
+82.3%
|
|
4Q22
|
6,523
|
+103.8%
|
|
3Q22
|
5,704
|
+134.7%
|
|
2Q22
|
4,773
|
+202.4%
|
|
1Q22
|
3,963
|
+162.1%
|
|
4Q21
|
3,201
|
+272.8%
|
|
3Q21
|
2,431
|
+855.2%
|
|
2Q21
|
1,578
|
-482.3%
|
|
1Q21
|
1,511
|
-220.9%
|
|
4Q20
|
858
|
-146.3%
|
|
3Q20
|
254
|
-110.4%
|
|
2Q20
|
-413
|
-83.4%
|
|
1Q20
|
-1,251
|
-54.7%
|
|
4Q19
|
-1,853
|
-38.0%
|
|
3Q19
|
-2,436
|
-46.3%
|
|
2Q19
|
-2,494
|
-46.6%
|
|
1Q19
|
-2,761
|
-43.4%
|
|
4Q18
|
-2,989
|
-41.6%
|
|
3Q18
|
-4,540
|
-13.0%
|
|
2Q18
|
-4,669
|
-8.8%
|
|
1Q18
|
-4,876
|
-5.0%
|
|
4Q17
|
-5,120
|
-4.7%
|
|
3Q17
|
-5,220
|
-3.4%
|
|
2Q17
|
-5,117
|
-4.7%
|
|
1Q17
|
-5,135
|
-3.2%
|
|
4Q16
|
-5,374
|
+2.1%
|
|
3Q16
|
-5,407
|
+4.2%
|
|
2Q16
|
-5,368
|
+5.4%
|
|
1Q16
|
-5,303
|
+8.1%
|
|
4Q15
|
-5,262
|
+11.8%
|
|
3Q15
|
-5,188
|
+14.6%
|
|
2Q15
|
-5,093
|
+16.8%
|
|
1Q15
|
-4,904
|
+16.8%
|
|
4Q14
|
-4,705
|
+18.6%
|
|
3Q14
|
-4,529
|
+12.9%
|
|
2Q14
|
-4,359
|
+12.1%
|
|
1Q14
|
-4,199
|
+9.6%
|
|
4Q13
|
-3,967
|
+12.6%
|
|
3Q13
|
-4,011
|
+16.4%
|
|
2Q13
|
-3,887
|
+14.7%
|
|
1Q13
|
-3,830
|
+15.2%
|
|
4Q12
|
-3,522
|
+3.1%
|
|
3Q12
|
-3,446
|
-3.6%
|
|
2Q12
|
-3,388
|
-10.7%
|
|
1Q12
|
-3,323
|
-8.2%
|
|
4Q11
|
-3,415
|
-0.9%
|
|
3Q11
|
-3,573
|
+9.5%
|
|
2Q11
|
-3,795
|
+24.2%
|
|
1Q11
|
-3,621
|
+26.8%
|
|
4Q10
|
-3,444
|
-
|
|
3Q10
|
-3,264
|
-
|
|
2Q10
|
-3,055
|
-
|
|
1Q10
|
-2,855
|
-
|